Literature DB >> 14592675

Pharmacologic and sensorimotor components of satiation in cigarette smoking.

Jed E Rose1, Frederique M Behm, Eric C Westman, James E Bates, Al Salley.   

Abstract

To examine mechanisms underlying satiation in cigarette smoking, 18 smokers received intravenous (i.v.) nicotine, alone or in combination with denicotinized cigarette smoke. Nicotine was administered using programmed presentations of either pulsed injections or continuous infusions, with i.v. saline serving as a control. A high-nicotine cigarette smoke condition (usual brand) was also presented. During each of the six test sessions, subjects were allowed to puff on their usual brands of cigarette ad libitum while the programmed satiation conditions were in force. Administration of i.v. nicotine caused a small suppression of ad libitum smoking behavior; denicotinized smoke produced a significantly larger reduction, showing that short-term satiation is more dependent on the presentation of smoke than delivery of nicotine per se. However, denicotinized smoke alone did not have as much effect as puffs from the usual brands of cigarettes. The combination of i.v. nicotine and denicotinized smoke puffs produced equivalent satiation to that of the usual brand. Cigarette craving and negative affect were partially relieved by iv nicotine presentations as well as by denicotinized smoke, and again the combination of i.v. nicotine and denicotinized smoke approximated the effects of the usual brand. The results of this study underscore the importance of both sensorimotor aspects of smoking and the pharmacologic effects of nicotine in tobacco dependence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14592675     DOI: 10.1016/j.pbb.2003.07.002

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  37 in total

1.  Abstinence-induced changes in self-report craving correlate with event-related FMRI responses to smoking cues.

Authors:  F Joseph McClernon; F Berry Hiott; Scott A Huettel; Jed E Rose
Journal:  Neuropsychopharmacology       Date:  2005-10       Impact factor: 7.853

2.  The role of nicotinic acetylcholine receptors in the primary reinforcing and reinforcement-enhancing effects of nicotine.

Authors:  Matthew I Palmatier; Xiu Liu; Anthony R Caggiula; Eric C Donny; Alan F Sved
Journal:  Neuropsychopharmacology       Date:  2006-11-08       Impact factor: 7.853

Review 3.  Nicotine reduction revisited: science and future directions.

Authors:  Dorothy K Hatsukami; Kenneth A Perkins; Mark G Lesage; David L Ashley; Jack E Henningfield; Neal L Benowitz; Cathy L Backinger; Mitch Zeller
Journal:  Tob Control       Date:  2010-10       Impact factor: 7.552

4.  Reinforcing effects of nicotine and non-nicotine components of cigarette smoke.

Authors:  Jed E Rose; Al Salley; Frederique M Behm; James E Bates; Eric C Westman
Journal:  Psychopharmacology (Berl)       Date:  2010-04-01       Impact factor: 4.530

Review 5.  Nicotine and nonnicotine factors in cigarette addiction.

Authors:  Jed E Rose
Journal:  Psychopharmacology (Berl)       Date:  2005-12-16       Impact factor: 4.530

6.  Nicotine as a typical drug of abuse in experimental animals and humans.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2005-10-05       Impact factor: 4.530

7.  Effectiveness of Non-Nicotinic E-Cigarettes to Reduce Cue- and Abstinence-Induced Cigarette Craving in Non-Treatment Seeking Daily Dependent Smokers.

Authors:  Ginnie Ng; Sophia Attwells; Peter Selby; Laurie Zawertailo
Journal:  Psychopharmacology (Berl)       Date:  2021-01-30       Impact factor: 4.530

8.  Sex differences in the influence of nicotine dose instructions on the reinforcing and self-reported rewarding effects of smoking.

Authors:  Kenneth A Perkins; Todd Doyle; Melinda Ciccocioppo; Cynthia Conklin; Michael Sayette; Anthony Caggiula
Journal:  Psychopharmacology (Berl)       Date:  2005-08-02       Impact factor: 4.530

9.  Comparative effectiveness of the nicotine lozenge and tobacco-free snuff for smokeless tobacco reduction.

Authors:  Jon O Ebbert; Herbert H Severson; Ivana T Croghan; Brian G Danaher; Darrell R Schroeder
Journal:  Addict Behav       Date:  2013-02-04       Impact factor: 3.913

Review 10.  Effects of nicotine in experimental animals and humans: an update on addictive properties.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Handb Exp Pharmacol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.